0
60 years experience focusing solely on Animal Health to help customers meet real-world challenges, pre-opens the 5th edition of the ESPHM (European Symposium of Porcine Health Management) with a satellite symposium focused on innovation in swine health and management, by presenting the news about the Suvaxyn portfolio (MH1 and PCV) and the IPC (Individual Pig Care) program. Later in the week, veterinarians are invited to attend Zoetis oral presentation session and general poster session, focused on Individual Pig Care and the latest results on Sow management studies, as latest activity of its commitment to swine full health solution.
Zoetis strives offering veterinarians and farmers innovative porcine prevention solutions such as Improvac®, a unique vaccine reducing boar taint avoiding surgical castration and very recently, Suvaxyn® PCV, the only vaccine recombining PCV1 and PCV2 in a single dose, that comes to complete the Suvaxyn range.
Focusing on its development of the vaccine range, during Zoetis Symposium, the presentation of the Mycoplasma vaccine study: “Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine”, demonstrated that Suvaxyn® MH1 induces both local and systemic immune responses involving both specific antibodies and cellular immunity, in pigs injected from 7 days of age and tested at 30, 36 and 58 days of age (1).
Zoetis, as a responsible company in Animal Health, aims as well at helping veterinarians to achieve a responsible use of anti-infective through a large and complete anti-infective portfolio allowing ad hoc usage of the right molecule, at the right moment in the right animal for a better health and a positive return.
“Our veterinary experts and researchers work closely with pork producers and veterinarians to help them make informed decisions that contribute to wellness in pigs and the production of safe, high-quality pork” says Frederique Clusel, Zoetis Group Director Swine Business Unit, Europe Africa Middle-East.
For Zoetis, preventive and responsible therapeutic solutions also means proposing its customers educational programs and tools providing a better understanding of the farm situation and enabling early identification and management of diseases, allowing effective treatment, optimizing treatments success and reducing costs. IPC, Individual Pig Care, was launched, in 2012, in Europe, to achieve those goals.
During the last Zoetis pre-ESPHM symposium in 2012, Professor Jens Nielsen, Head of Production and Health in the Department of Large Animal Sciences at the University of Copenhagen and chairman of the symposium, said that IPC reflected the changing needs of veterinarians: “The veterinary profession has been very much focused on products, and selling products to the farmer, and I think the future for the veterinary profession is to move from selling products to selling advice. To do that, they need information – some good solid data. I think IPC reflects a global trend. We need to focus on the individual animal both for the benefit of animal welfare, for better treatment of diseased animals and also to get better production – so you are in front of the problems rather than behind them”.
Professor Nielsen’s words are proving to be more than true after 1 year of the official launch of IPC in Europe and this is what Zoetis presented today as well.
The customers had the opportunity to discover, together with their Zoetis counterpart, the new tools developed into the program since April 2012: interactive and real-time updated dashboard, benchmarking system, comparative tool, ROI calculator and anti-infective calculator. Olivia Azlor, Zoetis Swine Marketing Solution Manager, pointed out that IPC program, using an electronic clinical scoring system, helped veterinarians and farmers treating 80% of sick pigs at early stage, when severity of disease is lower and success profitability of treatment is higher. The full study showing the outcomes of 1 year of IPC implementation will be presented during an oral presentation on the second day of the congress (2)
Zoetis, also takes the opportunity of the congress, to unveil the results of its work on Sow management: an experiment on 48 sows (32 gilts and 16 mature sows) evaluating the effect of hyper-immunization of gilts on productive and health status of their progenies (3). The results of this trial shows that hyper-immunization of gilts was efficient to improve productive performance and health status of their progeny during lactation and nursery periods
May 22, 2013 - Zoetis
